Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s):  XRTX

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.


TSXV:XRTX - Post by User

Post by SpaceLabson Sep 10, 2021 12:56pm
189 Views
Post# 33840302

Playing Glomerula Filtration Rate-GFR, I am LOADING here XRX

Playing Glomerula Filtration Rate-GFR, I am LOADING here XRXThose Big Guys out there are ROBBING your shares dirt CHEAP since they know what Xortx is about to bring, called GFR ,,,,your Kidney Function.

Every doctor will be prescribing this to keep your Kidney Healthy as we age. Clinical III Trial while on DAQ for 2 Medication is great.

II trial is the make or Break and XRX made it, now a bigger sample and off to the races to manufacture what is not out there.

DYDD,,,,,,still VERY CHEAP at 70cents/share compared to other Clinical trials III trading on DAQ !!
<< Previous
Bullboard Posts
Next >>